{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "2021", "item": "https://www.patentleaderboard.com/2021/"}, {"@type": "ListItem", "position": 3, "name": "Institut Pasteur", "item": "https://www.patentleaderboard.com/2021/company/institut-pasteur"}, {"@type": "ListItem", "position": 4, "name": "Pierre Lafaye", "item": "https://www.patentleaderboard.com/2021/inventor/fl:pi_ln:lafaye-1"}]}

Home › 2021 › Institut Pasteur › Pierre Lafaye

Pierre Lafaye — 2 Patents in 2021

IPInstitut Pasteur: 2 patents #3 of 85Top 4%

CNCNRS: 1 patents #100 of 966Top 15%

CEA: 1 patents #216 of 747Top 30%

FAF. Hoffmann-La Roche Ag: 1 patents #1 of 27Top 4%

Paris, FR: #94 of 1,196 inventorsTop 8%

Overall (2021): #122,403 of 548,734Top 25%

2 Patents 2021

Issued Patents 2021

Showing 1–2 of 2 patents

Patent #	Title	Co-Inventors	Date
11124563	Camelid single-domain antibody directed against phosphorylated tau proteins and methods for producing conjugates thereof	Sylvie Bay, Benoit Delatour, Marc Dhenain, Charles Duyckaerts, Tengfei Li +3 more	2021-09-21
10948490	Severe acute respiratory syndrome (SARS)—associated coronavirus diagnostics	Sylvie Van Der Werf, Nicolas Escriou, Caroline Demeret, Stéphane Petres, Jacques Bellalou	2021-03-16

Pierre Lafaye — 2 Patents in 2021

Issued Patents 2021

Patent Widget